A Clinical Study of IgA Nephropathy with Serum Hepatitis B Surface Antigen.
- Author:
Gyung Geun HAN
1
;
Jeong Ha PACK
;
Sung Jin BAE
;
Sam Ryong JI
;
Jeong Hyun LIM
;
Goang Yul JANG
;
Seong Eun KIM
;
Ki Hyun KIM
Author Information
1. Department of Internal Medicine, Dong-A University Hospital, Pusan, Korea.
- Publication Type:Original Article
- Keywords:
IgA nephropathy;
HBsAg;
Pathoge-nesis;
Prognosis
- MeSH:
Aspartate Aminotransferases;
Creatinine;
Glomerulonephritis, IGA*;
Hepatitis B Surface Antigens*;
Hepatitis B*;
Hepatitis*;
Humans;
Hypertension;
Immunoglobulin A*;
Incidence;
Prognosis;
Proteinuria
- From:Korean Journal of Nephrology
2000;19(3):437-443
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
There are some clinical evidences that hepatitis B virus(HBV) infection may cause IgA nephropathy. To evaluate clinical significances and pathogenetic roles of HBV infection in patients with IgA nephropathy, we studied that varius clinical and lab- oratory findings in 172 patients with IgA nephrop-athy as serum hepatitis B surface antigen (HBsAg) positive (19 cases) and negative group (153 cases). The result was as following: 1) The incidence of positive serum HRsAg was 11.0%(19/172 cases) in patients with IgA nephropathy and it was higher than that of the randomized age-sex matched general population(4.1%) but has no significance statistically. 2) There was no significant differences in incidence of hypertension, serum levels of IgA, C3, SGOT, SGFf between HBsAg postive and negative group. 3) The cases of nephrotic range proteinuria (3.5g/ day) was more prevalent in HBsAg positive group (31.6%) than that in negative group(7.2%). significantly (p<0.05). 4) The cases of impaired renal function (serum creatinine more than 1.4mg/dL) were more frequent in HBsAg positive group (42.19%) than that in neg-ative group (13.1%) significantly(p<0.05).
